• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二十余年来,初级预防 ICD 治疗的当代获益-危害特征。

Contemporary benefit-harm profile over two decades in primary prophylactic ICD-therapy.

机构信息

Klinikum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany.

出版信息

Clin Cardiol. 2019 Oct;42(10):866-872. doi: 10.1002/clc.23234. Epub 2019 Jul 17.

DOI:10.1002/clc.23234
PMID:31317573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6788478/
Abstract

BACKGROUND

Implantable cardioverter defibrillator (ICD) was implemented into clinical routine more than 20 years ago. Since then, ICD therapy became standard therapy for primary and secondary prevention of sudden cardiac death in clinical practice.

OBJECTIVES

Aim of the study was to evaluate the benefit-harm profile of contemporary primary prophylactic ICD therapy.

METHODS

A total of 1222 consecutive patients of a prospective single-center ICD-registry were analyzed who underwent primary prophylactic ICD implantation between 2000 and 2017. Patients were divided into two groups according to the implantation year: 2010-2017 (group 1, n = 579) and 2000-2009 (group 2, n = 643).

RESULTS

The rate of estimated appropriate ICD therapy after 8 years was 51% in the 2000s and 42% in the 2010s (P < .001). The complication rate changed slightly from 53% to 47% (P = .005). This decline was mainly driven by the reduction of inappropriate ICD shocks (30% vs 14%, P < .001) whereas the rate of ICD shock lead malfunction and device/ lead infection remained unchanged over time. Nonischemic cardiomyopathy was an independent predictor for ICD complications without benefit of ICD therapy (HR 1.37, 95% CI 1.07-1.77).

CONCLUSION

The ICD therapy rate for ventricular arrhythmias in patients with primary prophylactic ICD implantation is decreasing over the last two decades. Complication rate remains high due to an unchanged rate of ICD shock malfunctions and device infections. Nonischemic cardiomyopathy is an independent predictor for ICD complications without benefit of ICD therapy in primary prophylactic ICD-therapy.

摘要

背景

植入式心脏复律除颤器(ICD)在 20 多年前就已应用于临床常规。自那时起,ICD 治疗已成为临床实践中预防心源性猝死的主要和二级预防标准治疗方法。

目的

本研究旨在评估当代原发性预防性 ICD 治疗的获益-风险特征。

方法

对 2000 年至 2017 年间接受原发性预防性 ICD 植入的前瞻性单中心 ICD 注册中心的 1222 例连续患者进行了分析。根据植入年份将患者分为两组:2010-2017 年(组 1,n=579)和 2000-2009 年(组 2,n=643)。

结果

在 8 年后,2000 年代的适当 ICD 治疗估计率为 51%,而 2010 年代为 42%(P<.001)。并发症发生率从 53%略微降至 47%(P=0.005)。这种下降主要归因于不适当的 ICD 电击的减少(30%降至 14%,P<.001),而 ICD 电击导致的故障和器械/导线感染的发生率随着时间的推移保持不变。非缺血性心肌病是 ICD 并发症的独立预测因素,而 ICD 治疗没有获益(HR 1.37,95%CI 1.07-1.77)。

结论

在过去的二十年中,接受原发性预防性 ICD 植入的患者的室性心律失常 ICD 治疗率呈下降趋势。由于 ICD 电击故障和器械感染的发生率保持不变,并发症发生率仍然很高。非缺血性心肌病是非缺血性心肌病患者 ICD 并发症的独立预测因素,而 ICD 治疗没有获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/762f0abcb4d6/CLC-42-866-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/534a26a4a1e6/CLC-42-866-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/16f5be5a908d/CLC-42-866-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/62810399dd39/CLC-42-866-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/762f0abcb4d6/CLC-42-866-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/534a26a4a1e6/CLC-42-866-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/16f5be5a908d/CLC-42-866-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/62810399dd39/CLC-42-866-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49fe/6788478/762f0abcb4d6/CLC-42-866-g004.jpg

相似文献

1
Contemporary benefit-harm profile over two decades in primary prophylactic ICD-therapy.二十余年来,初级预防 ICD 治疗的当代获益-危害特征。
Clin Cardiol. 2019 Oct;42(10):866-872. doi: 10.1002/clc.23234. Epub 2019 Jul 17.
2
Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.睡眠呼吸障碍对植入式心脏除颤器用于预防心源性猝死的患者进行适当和不适当植入式心脏复律除颤器治疗的预测作用。
Am J Cardiol. 2013 May 1;111(9):1319-23. doi: 10.1016/j.amjcard.2013.01.277. Epub 2013 Feb 11.
3
Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.前瞻性多国 ICD 运动安全注册研究中的高强度娱乐运动员:来自欧洲队列的结果。
Eur J Prev Cardiol. 2019 May;26(7):764-775. doi: 10.1177/2047487319834852. Epub 2019 Feb 27.
4
Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.T 波电交替对植入式心脏复律除颤器一级预防获益无预后价值。
J Am Heart Assoc. 2024 Jun 4;13(11):e032465. doi: 10.1161/JAHA.123.032465. Epub 2024 May 28.
5
Arrhythmic burden among asymptomatic patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator.无症状缺血性心肌病合并植入式心脏复律除颤器患者的心律失常负担。
Heart Rhythm. 2019 Jun;16(6):813-819. doi: 10.1016/j.hrthm.2019.03.030.
6
Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry.当代单线圈与双线圈植入式心律转复除颤器导线植入的比率与结果:来自以色列 ICD 登记处的数据。
Europace. 2017 Sep 1;19(9):1485-1492. doi: 10.1093/europace/euw199.
7
Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.适当的植入式心脏复律除颤器治疗在二级预防患者中的死亡率影响:前瞻性基于人群的登记处中一级预防患者死亡率的对比。
J Am Heart Assoc. 2017 Aug 19;6(8):e006220. doi: 10.1161/JAHA.117.006220.
8
Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death.恰当的治疗可预测心源性猝死一级和二级预防的长期死亡率。
J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):110-3. doi: 10.2459/JCM.0b013e3283511f5b.
9
Performance of the entirely subcutaneous ICD in borderline indications.完全皮下植入式 ICD 在边缘适应症中的表现。
Clin Res Cardiol. 2020 Jun;109(6):694-699. doi: 10.1007/s00392-019-01558-z. Epub 2019 Oct 4.
10
Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病患者应用植入型心律转复除颤器进行心源性猝死的一级预防。
Am J Cardiol. 2019 Apr 1;123(7):1156-1162. doi: 10.1016/j.amjcard.2018.12.049. Epub 2019 Jan 8.

引用本文的文献

1
Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.T 波电交替对植入式心脏复律除颤器一级预防获益无预后价值。
J Am Heart Assoc. 2024 Jun 4;13(11):e032465. doi: 10.1161/JAHA.123.032465. Epub 2024 May 28.
2
Implantable Cardioverter-Defibrillator for Primary Prevention in Asia.亚洲用于一级预防的植入式心脏复律除颤器
JACC Asia. 2023 Mar 7;3(3):321-334. doi: 10.1016/j.jacasi.2022.11.014. eCollection 2023 Jun.
3
Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective.

本文引用的文献

1
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.皮下与经静脉植入式心脏除颤器治疗:病例对照研究的荟萃分析。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
2
Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.植入型心律转复除颤器治疗非缺血性心肌病患者的疗效:一项随机对照试验的系统评价和荟萃分析。
JACC Clin Electrophysiol. 2017 Sep;3(9):962-970. doi: 10.1016/j.jacep.2017.02.006. Epub 2017 May 31.
3
原发性预防植入式心脏除颤器:汤斯维尔地区视角
Front Cardiovasc Med. 2020 Oct 27;7:577248. doi: 10.3389/fcvm.2020.577248. eCollection 2020.
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
抗菌包膜与植入式心脏复律除颤器和心脏再同步治疗装置更换后的低感染率相关:Citadel 和 Centurion 研究的结果。
JACC Clin Electrophysiol. 2017 Oct;3(10):1158-1167. doi: 10.1016/j.jacep.2017.02.016. Epub 2017 May 31.
4
Implantable cardioverter defibrillator in nonischemic cardiomyopathy: A systematic review and meta-analysis.非缺血性心肌病中植入式心脏复律除颤器:一项系统评价和荟萃分析。
J Arrhythm. 2017 Dec 14;34(1):4-10. doi: 10.1002/joa3.12017. eCollection 2018 Feb.
5
Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.医生的指南遵循与射血分数降低的心力衰竭门诊患者的更好预后相关:QUALIFY 国际注册研究。
Eur J Heart Fail. 2017 Nov;19(11):1414-1423. doi: 10.1002/ejhf.887. Epub 2017 Apr 30.
6
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。
Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.
7
Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice.社区实践中十年间用于一级预防的除颤器治疗的时间趋势
J Cardiovasc Electrophysiol. 2017 Jun;28(6):666-673. doi: 10.1111/jce.13198. Epub 2017 Apr 18.
8
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者的除颤器植入
N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27.
9
Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association.欧洲心脏病学会成员国心脏植入式电子设备及介入性电生理手术的当前使用趋势:欧洲心律协会2015年报告
Europace. 2015 Aug;17 Suppl 4:iv1-72. doi: 10.1093/europace/euv265.
10
Spectrum of issues detected by an ICD diagnostic alert that utilizes far-field electrograms: Clinical implications.利用远场电图的ICD诊断警报检测到的问题范围:临床意义。
Heart Rhythm. 2015 May;12(5):957-67. doi: 10.1016/j.hrthm.2015.01.047. Epub 2015 Jan 29.